SPX3,963.51+29.59 0.75%
DIA338.46+2.02 0.60%
IXIC11,082.00+123.45 1.13%

Compugen Expects to Receive $7.5 Million Milestone Payment From AstraZeneca as Mid-Stage Study of AZD2936 Begins

Compugen Expects to Receive $7.5 Million Milestone Payment From AstraZeneca as Mid-Stage Study of AZD2936 Begins

MT Newswires · 11/16/2022 04:45

Please log in to view news